April, 2017 – AACR

Multimeric Anti-DR5 IgM antibody displays potent cytotoxicity in vitro and promotes tumor regression in vivo. 

Read More

April, 2016 – PEGS

High Avidity Anti-CD20 IgM Antibody for Enhanced Complement-Dependent Cell Killing of Low CD20 Expressing Tumor Cells. View the full poster here (623 Kb PDF)

Read More

April, 2014 – AACR

IGM-55.5, a novel monoclonal human recombinant IgM antibody with potent activity against B cell leukemia and lymphoma. View the full poster here. (940Kb PDF)

Read More